Inho Kim

1.1k total citations
38 papers, 619 citations indexed

About

Inho Kim is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Inho Kim has authored 38 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Inho Kim's work include Venous Thromboembolism Diagnosis and Management (6 papers), Neutropenia and Cancer Infections (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Inho Kim is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Neutropenia and Cancer Infections (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Inho Kim collaborates with scholars based in South Korea, Puerto Rico and United States. Inho Kim's co-authors include Soo‐Mee Bang, Sung‐Soo Yoon, Yun‐Gyoo Lee, Diana Delgado, Zachary M. Grinspan, Rainu Kaushal, Samantha K. Brenner, Erika L. Abramson, Christine Joyce and Rhonda J. Allard and has published in prestigious journals such as Blood, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Inho Kim

37 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inho Kim South Korea 14 176 153 125 124 107 38 619
Caroline Shiach United Kingdom 17 323 1.8× 241 1.6× 41 0.3× 345 2.8× 76 0.7× 47 899
Christine Le Beller France 13 67 0.4× 76 0.5× 63 0.5× 46 0.4× 69 0.6× 23 513
Nicole Adler United States 7 50 0.3× 50 0.3× 98 0.8× 32 0.3× 45 0.4× 11 527
Allison Burnett United States 7 61 0.3× 388 2.5× 126 1.0× 331 2.7× 27 0.3× 8 755
Gorana Mitić Serbia 15 248 1.4× 130 0.8× 20 0.2× 142 1.1× 26 0.2× 43 663
Ejler Ejlersen Denmark 13 75 0.4× 53 0.3× 24 0.2× 107 0.9× 43 0.4× 23 515
Leo van de Watering Netherlands 14 566 3.2× 37 0.2× 33 0.3× 36 0.3× 61 0.6× 31 1.4k
Jérémie Riou France 14 59 0.3× 55 0.4× 38 0.3× 62 0.5× 83 0.8× 74 640
Alberto Zanetto Italy 25 52 0.3× 107 0.7× 112 0.9× 70 0.6× 116 1.1× 126 1.7k
Alex L. Chang United States 15 43 0.2× 15 0.1× 88 0.7× 50 0.4× 161 1.5× 36 945

Countries citing papers authored by Inho Kim

Since Specialization
Citations

This map shows the geographic impact of Inho Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inho Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inho Kim more than expected).

Fields of papers citing papers by Inho Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inho Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inho Kim. The network helps show where Inho Kim may publish in the future.

Co-authorship network of co-authors of Inho Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Inho Kim. A scholar is included among the top collaborators of Inho Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inho Kim. Inho Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Chang Won, Inho Kim, Dong‐Yeop Shin, et al.. (2022). Monitoring energy balance through clinical and serum biomarkers in patients with hematologic malignancies undergoing chemotherapy. Annals of Hematology. 101(12). 2759–2769. 3 indexed citations
3.
4.
Lee, Sungyoung, Inho Kim, Sung‐Soo Yoon, et al.. (2020). MED-TMA: A clinical decision support tool for differential diagnosis of TMA with enhanced accuracy using an ensemble method. Thrombosis Research. 193. 154–159. 4 indexed citations
5.
Kim, Inho, et al.. (2019). The importance of physical function in patients with multiple myeloma for improving quality of life. Supportive Care in Cancer. 28(5). 2361–2367. 6 indexed citations
6.
Byun, Ja Min, Jeong‐Ok Lee, Koung Jin Suh, et al.. (2019). The Role of Anthracyclines in Acute Myeloid Leukemia Consolidation. Anticancer Research. 40(1). 357–366. 1 indexed citations
7.
Suh, Hyeon Jeong, Seo Hyun Yoon, Kyung‐Sang Yu, et al.. (2018). The Genetic Polymorphism UGT1A4*3 Is Associated with Low Posaconazole Plasma Concentrations in Hematological Malignancy Patients Receiving the Oral Suspension. Antimicrobial Agents and Chemotherapy. 62(7). 20 indexed citations
8.
Cha, Seungwoo, Inho Kim, Shi-Uk Lee, & Kwan Sik Seo. (2018). Effect of an Inpatient Rehabilitation Program for Recovery of Deconditioning in Hematologic Cancer Patients After Chemotherapy. Annals of Rehabilitation Medicine. 42(6). 838–845. 3 indexed citations
9.
Suh, Hyeon Jeong, Inho Kim, Joo‐Youn Cho, et al.. (2017). Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies. Infection and Chemotherapy. 49(2). 135–135. 11 indexed citations
10.
Park, Wan Beom, Joo‐Youn Cho, Eun Jung Kim, et al.. (2016). Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy. International Journal of Antimicrobial Agents. 48(1). 106–110. 14 indexed citations
11.
Kım, Kihyun, Dok Hyun Yoon, Jin Seok Kim, et al.. (2014). Clinical Factors Associated with Response or Survival after Chemotherapy in Patients with Waldenström Macroglobulinemia in Korea. BioMed Research International. 2014. 1–7. 3 indexed citations
12.
Lee, Yun‐Gyoo, Eunyoung Lee, Soo‐Mee Bang, et al.. (2014). Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer. Thrombosis and Haemostasis. 111(6). 1112–1120. 66 indexed citations
13.
Kim, Sojin, et al.. (2013). Potentiating Effect of Glabridin on GABAA Receptor-Mediated Responses in Dorsal Raphe Neurons. Planta Medica. 79(15). 1408–1412. 26 indexed citations
14.
Kim, Ki Hwan, Hyo-Jeong Lim, Jin-Soo Kim, et al.. (2010). Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute. Cytotherapy. 13(4). 490–498. 24 indexed citations
15.
Kim, Dae‐Young, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2009). Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine. Annals of Hematology. 89(1). 15–23. 9 indexed citations
16.
Kim, Seok Jin, Kihyun Kım, Byung‐Soo Kim, et al.. (2008). Bortezomib and the Increased Incidence of Herpes Zoster in Patients with Multiple Myeloma. Clinical Lymphoma & Myeloma. 8(4). 237–240. 48 indexed citations
17.
Kim, Tae Min, Jin Soo Kim, Yong Sang Hong, et al.. (2008). Clinical predictors of recurrent venous thromboembolism: A single institute experience in Korea. Thrombosis Research. 123(3). 436–443. 23 indexed citations
18.
Hur, Jong-Moon, et al.. (2007). Hepatoprotective Effect of Catechin Isolated from the Root of Rosa rugosa Thunb. Korean Journal of Medicinal Crop Science. 15(1). 21–25. 2 indexed citations
19.
Bang, Myun‐Ho, Myoung‐Chong Song, Jiyoung Kim, et al.. (2003). Development of Biologically Active Compound from Edible Plant Sources -V. -Phytol, ACAT (Acyl-CoA: Cholesterol Acyltransferase) Inhibitory Diterpenoid From the Leaves of Lactuca sativa L.-. Applied Biological Chemistry. 46(1). 66–68. 1 indexed citations
20.
Kim, Sun‐Joo, Seungwon Jung, Hwan-Yeol Kim, et al.. (2002). Analysis of Seasonal Variation and Risk factors of Esophageal Variceal Bleeding in Patients with Cirrhosis. Korean Journal of Gastroenterology. 40(6). 386–393. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Shiach Breakdown of academic impact, for papers by Christine Le Beller Breakdown of academic impact, for papers by Nicole Adler Breakdown of academic impact, for papers by Allison Burnett Breakdown of academic impact, for papers by Gorana Mitić Breakdown of academic impact, for papers by Ejler Ejlersen Breakdown of academic impact, for papers by Leo van de Watering Breakdown of academic impact, for papers by Jérémie Riou Breakdown of academic impact, for papers by Alberto Zanetto Breakdown of academic impact, for papers by Alex L. Chang
Rankless by CCL
2026